D61.810

Clinical Causes: Treatment with chemotherapy drugs that target rapidly dividing cells, including healthy blood cells. Cumulative effects of chemotherapy over multiple cycles. Pre-existing bone marrow disorders that might exacerbate the effects of chemotherapy. Combination of chemotherapy with radiation therapy or other treatments that suppress bone marrow function.

Key Symptoms: Increased fatigue and weakness due to anemia (low red blood cells). Unusual bleeding or easy bruising resulting from low platelet counts. Frequent or severe infections caused by a reduced number of white blood cells (neutropenia). Shortness of breath and dizziness. Fever without clear infection signs. Pale skin, especially noticeable in the face and inside the mouth.

Diagnosis Path: Diagnosing pancytopenia involves blood tests such as a complete blood count (CBC). This test measures the levels of red blood cells, white blood cells, and platelets. If these counts are significantly below normal, further tests like bone marrow biopsies may be performed to assess marrow health and rule out other conditions. Medical history, including recent chemotherapy treatments, is also considered to establish the connection between therapy and the blood cell deficiency.

Treatment Protocols: Managing chemotherapy-induced pancytopenia focuses on supporting blood cell counts and preventing complications. Common approaches include: - Dose adjustment or temporary cessation of chemotherapy. - Blood transfusions to address anemia or low platelet counts. - Growth factors such as erythropoietin or colony-stimulating factors to stimulate blood cell production. - Antibiotics or antifungal medications to treat or prevent infections. - Careful monitoring of blood counts throughout treatment. In some cases, doctors may recommend additional treatments or supportive measures based on individual patient needs. The goal is to ensure safety while maintaining efficacy in cancer therapy.